Incyte
American pharmaceutical company
INCY Nasdaq
ISIN US45337C1027 SEC CIK 879169 LEI 549300Z4WN6JVZ3T4680
Follow Incyte
Weekly email: filings, results
Revenue, last quarter
$1.6B
+14% vs same quarter last year
Net income
−$784.8M
−285% vs same quarter last year
EPS, diluted
−$3.86
−282.9% vs same quarter last year
Operating cash flow
−$675.3M
−220.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $5.1B | $1.3B |
| FY24 | $4.2B | $32.6M |
| FY23 | $3.7B | $597.6M |
| FY22 | $3.4B | $340.7M |
| FY21 | $3B | $948.6M |
| FY20 | $2.7B | −$295.7M |
| FY19 | $2.2B | $446.9M |
| FY18 | $1.9B | $109.5M |
| FY17 | $1.5B | −$313.1M |
| FY16 | $1.1B | $104.2M |
| FY15 | $753.8M | $6.5M |
| FY14 | $511.5M | −$48.5M |
| FY13 | $354.9M | −$83.1M |
| FY12 | $297.1M | −$44.3M |
| FY11 | $94.5M | −$186.5M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 92.8% | 29.5% | 25% |
| FY24 | 92.6% | 1.4% | 0.8% |
| FY23 | 93.1% | 16.8% | 16.2% |
| FY22 | 93.9% | 17.1% | 10% |
| FY21 | 94.9% | 19.6% | 31.8% |
| FY20 | 95.1% | −9.9% | −11.1% |
| FY19 | 94.7% | 18.6% | 20.7% |
| FY18 | 95% | 6.9% | 5.8% |
| FY17 | 94.8% | −15.8% | −20.4% |
| FY16 | 94.7% | 13.1% | 9.4% |
| FY15 | 96.4% | 6.7% | 0.9% |
| FY14 | 99.4% | −0.9% | −9.5% |
| FY13 | 99.8% | −4.5% | −23.4% |
| FY12 | 99.9% | 0.4% | −14.9% |
| FY11 | - | −151.6% | −197.5% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | - |
| FY22 | $892.1M |
| FY21 | $568.5M |
| FY20 | −$312M |
| FY19 | $632.6M |
| FY18 | $262.7M |
| FY17 | −$204M |
| FY16 | $184.5M |
| FY15 | $63.4M |
| FY14 | −$1.6M |
| FY13 | $4.9M |
| FY12 | −$97.7M |
| FY11 | −$165.5M |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $0 |
| FY24 | $2B |
| FY23 | $0 |
| FY22 | $0 |
| FY21 | - |
| FY20 | - |
| FY19 | - |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | - |
| FY14 | - |
| FY13 | - |
| FY12 | - |
| FY11 | - |
- Incyte
- Healthcare median
Show the numbers
| Year | Incyte | Healthcare median |
|---|---|---|
| FY25 | 25% | −30.6% |
| FY24 | 0.8% | −47% |
| FY23 | 16.2% | −58% |
| FY22 | 10% | −80.4% |
| FY21 | 31.8% | −71.9% |
| FY20 | −11.1% | −62.2% |
| FY19 | 20.7% | −46.3% |
| FY18 | 5.8% | −49.6% |
| FY17 | −20.4% | −45.9% |
| FY16 | 9.4% | −36% |
| FY15 | 0.9% | −38.4% |
| FY14 | −9.5% | −35.5% |
| FY13 | −23.4% | −37.1% |
| FY12 | −14.9% | −29.1% |
| FY11 | −197.5% | −27.9% |